Phase 2 Readout~quarter

Phase 2 Readout: sabirnetug

December 31, 2026

Company: Acumen Pharmaceuticals, Inc. (ABOS)
Drug: sabirnetug

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start Free Full Calendar

Phase 2 Readout: sabirnetug — ABOS Phase 2 Readout | BioSniper